BearingPoint Study Unveils Three Steps for Enhanced Welfare Services
1.8.2023 09:55:00 EEST | Business Wire | Press release
Management and technology consultancy BearingPoint has released its latest study, “Digital delivery holds the key for enabling better welfare services,” which examines the digital maturity of social welfare services across ten countries in Europe, North America, and Asia-Pacific. The study assesses the state of various social welfare programs, focusing on core industry digital dimensions and social protection categories, and highlights how governments are leveraging digital transformation to meet evolving socio-economic needs and introducing innovative solutions. The study identifies three crucial steps for government ministries and agencies responsible for social welfare services to enhance well-being outcomes for citizens:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230801342246/en/
• Reorient social welfare services around citizen segments and specific needs
• Rethink how to deliver true change and transformation in the delivery of services
• Realize tangible social and economic benefits for both public servants and citizens
This study explores why these actions are necessary, outlining what government leaders must do now and the anticipated benefits and outcomes.
Andrew Montgomery, Global Leader Government and Public Sector at BearingPoint, states: “Social welfare services form a significant part of annual expenditure for all governments, both in terms of citizen payments and service delivery costs. Our research and client experience highlights how digital and innovative technologies can improve the alignment of services with citizen needs, enable quicker responses to changing socio-economic conditions and ensure effective allocation of social welfare budgets.”
The global social welfare digital services leaders
As social welfare is a vast domain with many evolving digital developments, a simple, single-dimension maturity model would not provide any meaningful insight. Therefore, the study’s approach was multi-dimensional, examining the global digital service maturity of social welfare benefits across four digital dimensions and six social welfare categories. Of the ten countries assessed for their achievements in digitalizing access to social welfare services, the research shows that countries like Singapore, France, and Canada are typically at a higher level of digital maturity than others and offer leading practice examples. Singapore was the most digitally mature globally.
Countries were assessed on a score from 1-5 across four of the OECD’s Digital Dimensions (Digital by Design, User Driven, Government as a Platform, and Proactiveness) and the EU/EEA’s MISSOC Social Protection Categories (Unemployment, Health, Incapacity, Old-Age & Survivors, Family, and Social Assistance).
Digital by Design was the strongest dimension, with all countries optimized for digital applications and achieving an average score of 3.9 out of 5 across all categories. Proactiveness was the lowest scoring dimension across all categories, with an average aggregate score of 3.1, with opportunities identified for websites to include proactive prompts or auto-enrolment functionality.
Digital maturity in Unemployment is the strongest scoring (81%) and Incapacity (64%) the lowest in the MISSOC Social Protection Categories (Unemployment, Health, Incapacity, Old-Age & Survivors, Family, and Social Assistance).
About the study
The study examines the global digital service maturity of social welfare benefits across ten countries (Canada, Denmark, Estonia, France, Germany, Ireland, New Zealand, Norway, Singapore, and the UK), four digital dimensions, and six social welfare categories. It was based on desk-based research and validated with local contacts.
Download the study to find out more: https://www.bearingpoint.com/en/insights-events/insights/digital-strategy-for-citizens-well-being/
About BearingPoint
BearingPoint is an independent management and technology consultancy with European roots and a global reach. The company operates in three business units: Consulting, Products, and Capital. Consulting covers the advisory business with a clear focus on selected business areas. Products provides IP-driven digital assets and managed services for business-critical processes. Capital delivers M&A and transaction services.
BearingPoint’s clients include many of the world’s leading companies and organizations. The firm has a global consulting network with more than 10,000 people and supports clients in over 70 countries, engaging with them to achieve measurable and sustainable success.
For more information, please visit:
Homepage: www.bearingpoint.com
LinkedIn: www.linkedin.com/company/bearingpoint
Twitter: @BearingPoint
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230801342246/en/
Contact information
Alexander Bock
Global Senior Manager Communications
Telephone: +49 89 540338029
E-Mail: alexander.bock@bearingpoint.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz ® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 16:29:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “Today’s positive CHMP opinion is an important step towards addressing the urgent need for new treatment options for patients in Europe with advanced SCAC, a disease which has seen limited innovation for decades,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved, Zynyz in combination with platinum-based chemotherapy has the potential to become a new standard-of-care for patients living with this rare and difficult-to-treat cancer.” The positive CHMP opinion was based on data from the Phase 3 POD1UM-303/Inter
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 14:32:00 EET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 10:00:00 EET | Press release
With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerful, secure, reliable, and intelligent digital signage,” said Steve Durkee, chief executive office
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 09:30:00 EET | Press release
Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, supported by one of the largest bodies of published clinical data backed by decades of clinica
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 09:00:00 EET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
